Filing Details
- Accession Number:
- 0001209191-13-029203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-28 18:15:16
- Reporting Period:
- 2013-05-24
- Filing Date:
- 2013-05-28
- Accepted Time:
- 2013-05-28 18:15:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516479 | Insys Therapeutics Inc. | INSY | Pharmaceutical Preparations (2834) | 510327886 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1114913 | Pierre Lapalme | C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-24 | 2,000 | $10.39 | 2,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2013-05-24 | 1,000 | $10.39 | 1,000 | No | 4 | P | Indirect | By spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | By spouse |
Footnotes
- The weighted average sales price for the transaction reported was $10.38792, and the range of prices were between $10.38 and $10.3899. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The weighted average sales price for the transaction reported was $10.39447, and the range of prices were between $10.38 and $10.40. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
Billionaire Hedge Funds
